Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Recurrence
×
pepinemab
×
Clear all
Filters
3
NCT04815720
2025-01-08
KEYNOTE-B84
Vaccinex Inc.
Phase 1/2
Completed
49 enrolled